Omada Health (OMDA) is a strong buy. Backed by 29 studies, key partnerships with Cigna and CVS drive growth, credibility, and market expansion. See more here.

Revenue of $61 million, up 49%52%Member Growth and Significant Progress Toward Profitability SAN FRANCISCO, Aug. 07, 2025 (GLOBE NEWSWIRE) --  Omada Health, Inc. (Nasdaq: OMDA), the virtual ...

Drivers of revenue growth included more customers using multiple chronic condition programs as well as strong adoption of GLP ...

More than 100 companies have gone public this year, with Circle and CoreWeave delivering standout performances. As key lockup ...

Healthcare startups are betting that AI can help them do more with less — including in caring for patients.

Louisiana State Employees Retirement System decreased its position in Astrana Health, Inc. (NASDAQ:ASTH – Free Report) by 2.5% in the 1st quarter, according to its most recent Form 13F filing ...

Virtual chronic care company Omada Health will report second-quarter results on Aug. 7, which will be the first time the company has disclosed financials since its June debut on the Nasdaq.

Nutex Health (NASDAQ:NUTX) quickly fell 18% after a short call from Blue Orca Capital. Blue Orca Capital disclosed that it's short Nutex Health (NASDAQ:NUTX). Nutex Health didn't immediately ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.

New York State Common Retirement Fund trimmed its position in shares of Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 12.8% in the 1st quarter, according to the company in its most ...

The Beauty Health Company will report Q2 2025 financial results on August 7, 2025, with an investor call at 4:30 p.m. ET.